Company intelligence / Profile preview

Molecular Response Laboratories

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Molecular Response was a leader in advancing targeted therapeutics through intelligently designed, clinically validated companion diagnostics. The company developed proprietary ex vivo three-dimensional tumor growth assay technology covering 16 tumor types and maintained an extensive cancer biobank of over 100,000 viable tumors.[7]

Therapeutic areas: Oncology
Modalities: Cell therapyEx vivo assay platforms
Industry: Drug Discovery Services

Partnerships

Transparent Inc. (launched Cell-able Oncology platform in partnership)Scripps Genomic Medicine (joint discovery and development partnership)

Beyond the preview

Go deeper on Molecular Response Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Response Laboratories.

Explore the full profile